Protective potency of oil-treated cell walls of various mycobacteria against airborne infection of mice with a few cells of Mycobacterium tuberculosis H37Rv was compared with that of viable BCG. Although less potent than BCG cell walls, the cell walls of atypical mycobacteria of Runyon's groups I to IV protected against challenge by aerosol to some degree. Protection afforded by cell walls of H37Rv and of the avirulent mutants H37Ra and Washington II was comparable to that provided by BCG cell walls. However, cell walls ofa highly virulent strain of M. bovis (Bovinus I) provided the best protection yet achieved. Present evidence suggests that protective substances are shared by all mycobacteria but in differing amounts; the relationship between virulence and immunogenicity has yet to be clarified.
It has been reported that lyophilized cell walls of Mycobacterium bovis, strain BCG, and M. tuberculosis, strain H37Ra, ground to a paste with a small quantity of mineral oil or the synthetic hydrocarbon 7-n-hexyloctadecane and then suspended in saline containing 0.2% Tween 80, stimulated resistance in mice to aerosol challenge with a few viable cells of M. tuberculosis H37Rv (10, 12) . This type of immunity was shown to persist for at least 6 months (1) . Although cell walls protected mice against challenge by either the intravenous or respiratory route, the aerosol challenge test has been adopted as the method of choice for the evaluation of experimental vaccines because (i) it closely simulates natural infection of man, and (ii) only mycobacteria or appropriate mycobacterial fractions have been found to enhance resistance to pulmonary infection (11) , whereas nonspecific materials such as endotoxin (3, 7, 11) , ferritin (I. Millman, personal communication), and Escherichia coli ribosomes (9) promote resistance to intravenous challenge with virulent tubercle bacilli.
Recently it was learned that in an effective vaccine the cell walls are layered on the surface of minute oil droplets (2). Any factor or treatment which inhibited the association of cell walls with oil droplets, such as the presence of a large quan-tity of the emulsifying agent Tween 80 or prior extraction of the cell walls with ether, ethyl alcohol, and chloroform, also reduced or abolished the potency of the vaccine (9) . Even though we now know that in a potent vaccine, the mycobacterial cell walls are on the surface of the oil droplets, contrary to our earlier concept that the oil coated the cell wall, we have continued to use, for the sake of convenience, the expression "oil-treated cell walls."
This study was undertaken to determine the degree of immunity conferred by cell walls from human and bovine strains of tubercle bacilli with varying degrees of virulence and from atypical mycobacteria of Runyon's groups I to IV.
IMMUNOGENICITY OF MYCOBACTERIAL CELL WALLS
Cultivation. All strains were maintained on Hohn or Ldwenstein-Jensen medium with the exception of BCG, which was maintained on Sauton's potato medium. They were subcultured twice in Sauton's liquid medium, with the exception of strain Bovinus I which was subcultured in Long's medium. For vaccine production, each strain was grown for 10 to 18 days as a pellicle on the appropriate medium, and the cells were harvested on a sterile gauze filter, supported by a stainless-steel screen, and washed twice with distilled water.
Preparation of cell walls. Cell walls from all strains were prepared by the method described previously for BCG (10) . The degree of cell disruption was estimated by electron microscopy.
Preparation of vaccines. Vaccines of all cell wall preparations were made by the method described earlier (1) , except that the vaccines were used within 24 hr of preparation and were not frozen. The viable BCG standard vaccine was supplied through the courtesy of Sol Roy Rosenthal, University of Illinois, Chicago, and prepared for use as described previously (10) .
Protection test. The test was performed as previously described (10 
RESULTS
Ihmunogenicity of cell wallsfrom atypical mycobacteria. Oil-treated cell walls from representative mycobacteria of Runyon's groups I to IV were compared with oil-treated BCG cell walls and viable BCG for their ability to protect mice against aerosol challenge with M. tuberculosis H37Rv ( Table 1) However, for the 400-,ug dose a 2 log lower count (3.4 x 102) than for the 300-,ug dose of viable BCG (1.9 X 104) and a 4 log lower count than for the unvaccinated controls were noted. Higher doses of viable BCG usually do not significantly increase this order of protection (10) . The next best protection was afforded by cell walls from M. avium and from the Battey bacillus (group III); they also protected mice as well or better than did viable BCG, whereas the protection afforded by cell walls from M. aquae (group II) was comparable to that afforded by viable BCG. Cell walls prepared from M. smegmatis, classified with the saprophytic mycobacteria in Runyon's group IV, provided the lowest degree of protection; the median count was only 1 log lower than that of the controls. Results from other experiments (not shown) demonstrated that oil-treated cell walls from other mycobacteria ofgroup IV, M. fortuitum and M. phlei, also protected to the same low degree as did M. smegmatis.
As shown by Barclay et al. (2), a particular association of oil and cell walls is essential for a BCG cell-wall vaccine to be effective. Consequently, the vaccine of low potency made with cell walls of M. smegmatis was examined for the stability of this association in the diluted emulsion. The oil droplets were coated with cell-wall material, and it would appear, therefore, that the low protective potency of cell walls from saprophytic mycobacteria is due to lower immunogenicity rather than to insufficient coating of the droplets (Fig. 1) .
Immunogenicity of cell walls from M. tuberculosis. Cell-wall vaccines prepared from the avirulent mutants H37Ra and Washington II, from the attenuated strain R1Rv, and from the (group A) and of unvaccinated control mice (group B) month after aerosol challenge are shown in Fig. 2 . All lungs of the unvaccinated control mice have large nodular tubercles up to 3 mm in diameter, whereas no tubercles can be observed in lungs of mice which were vaccinated with the cell walls.
DISCUSSION
The results of these experiments suggest that all species of mycobacteria so far tested share in their cell wall a common factor which enhances resistance of mice to pulmonary infection with virulent tubercle bacilli. To achieve resistance against this type of infection, it is necessary to treat the mycobacterial cell walls with small amounts of mnineral oil. Although less potent than oil-treated BCG cell walls, the oil-treated cell walls of atypical mycobacteria of Runyon's groups I to IV had a measurable protective effect. The efficacy of cell walls from M. kansasii was notable (group I): 400 lAg of these cell walls were as potent as 200 jAg of BCG cell walls (see Table 1 ). Similarly, Larson and Wicht (5) found that viable M. kansasii and H37Ra given to mice by the respiratory route were equally effective against aerosol challenge with H37Rv. However, in their experiments, viable mycobacteria of groups II, III, and IV were not effective when administered by aerosol. Results of protection tests in other laboratories, experiments in which mice were inoculated with various living mycobacteria of groups I to IV and challenged intravenously with large doses of H37Rv, were strikingly similar to our results with the aerosol challenge test. Youmans et al. (15) found viable M. kansasii superior to viable mycobacteria of Runyon's groups II, III, and IV. Organisms of group II were found less effective than those of group III, and mycobacteria of group IV failed to enhance resistance. Siebenmann and Barbara (13) , using the same test system in mice, found a similar order of vaccine potency of viable atypical mycobacteria.
This ranking of various atypical mycobacteria in order of vaccine potency has also been demonstrated in survival tests with guinea pigs by Freerksen (4) , Palmer and Long (8) , and Vandiviere (14) . Accordingly, against subcutaneous or intraperitoneal challenge, M. kansasii was most effective (although less so than BCG), whereas strains of Runyon's group IV afforded the lowest degree of protection. From the results of these experiments with different host species and different methods of infection and evaluation, it is tempting to conclude that the same immunogenic factor or factors that are responsible for enhancement of resistance to infection with virulent tubercle bacilli produced by viable vaccines of mycobacteria are operative when corresponding oil-treated cell walls are used for immunization.
In this study, cell walls from M. smegmatis or M. phlei were found to coat mineral oil droplets readily (Fig. 1) , but the protection afforded was less than that of BCG cell walls. In view of the results of comparative protection tests with viable typical and atypical mycobacteria discussed above and with oil-treated cell walls of such mycobacteria reported in this paper, it would appear that the lower vaccine potency of cell walls from atypical mycobacteria is due to lower inherent immunogenicity of the cell walls rather than to insufficient coating of the oil droplets. Whether this proposed common protective factor is of the same chemical nature and present in different quantities in various mycobacterial species or whether there exists a system of chemically related factors which differ in potency has yet to to be determined. In the search for a more effective nonliving prophylactic against tuberculosis, the finding that oil-treated cell walls from the virulent strain Bovinus I had greater protective potency than did oil-treated BCG cell walls or viable attenuated mycobacteria was encouraging. The hope for practical use of such a vaccine, however, depends upon the outcome of efforts to eliminate the excessive granulomatous response (1, 2) without impairment of the ability to enhance resistance to tuberculous infection.
